Moreover, DDR1 depletion with two different shRNAs strongly inhibited the invasive capacities of KRAS‐mutated HCT116 and BRAF‐mutated HT29 CRC cells in vitro (Fig 2A–C). This evidence concerns the gene KRAS and colorectal carcinoma.